
### [NCIT:C4863](http://purl.obolibrary.org/obo/NCIT_C4863)
**Label:** Prostate Carcinoma

**Subclasses:** [NCIT:C6813](http://purl.obolibrary.org/obo/NCIT_C6813) (Prostate Ductal Adenocarcinoma), [NCIT:C7902](http://purl.obolibrary.org/obo/NCIT_C7902) (Recurrent Prostate Carcinoma), [NCIT:C48596](http://purl.obolibrary.org/obo/NCIT_C48596) (Invasive Prostate Carcinoma), [NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern), [NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern), [NCIT:C2919](http://purl.obolibrary.org/obo/NCIT_C2919) (Prostate Adenocarcinoma), [NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern), [NCIT:C103817](http://purl.obolibrary.org/obo/NCIT_C103817) (Hereditary Prostate Carcinoma), [NCIT:C27916](http://purl.obolibrary.org/obo/NCIT_C27916) (Poorly Differentiated Prostate Adenocarcinoma), [NCIT:C36308](http://purl.obolibrary.org/obo/NCIT_C36308) (Prostate Carcinoma Metastatic in the Bone), [NCIT:C36307](http://purl.obolibrary.org/obo/NCIT_C36307) (Prostate Carcinoma Metastatic in the Lung), [NCIT:C39898](http://purl.obolibrary.org/obo/NCIT_C39898) (Primary Prostate Urothelial Carcinoma), [NCIT:C5536](http://purl.obolibrary.org/obo/NCIT_C5536) (Prostate Squamous Cell Carcinoma), [NCIT:C132881](http://purl.obolibrary.org/obo/NCIT_C132881) (Metastatic Prostate Carcinoma in the Soft Tissue), [NCIT:C5538](http://purl.obolibrary.org/obo/NCIT_C5538) (Prostate Adenosquamous Carcinoma), [NCIT:C8946](http://purl.obolibrary.org/obo/NCIT_C8946) (Metastatic Prostate Carcinoma), [NCIT:C5539](http://purl.obolibrary.org/obo/NCIT_C5539) (Prostate Adenoid Cystic Carcinoma), [NCIT:C8945](http://purl.obolibrary.org/obo/NCIT_C8945) (Metastatic Prostatic Adenocarcinoma), [NCIT:C6766](http://purl.obolibrary.org/obo/NCIT_C6766) (Prostate Small Cell Carcinoma), [NCIT:C5596](http://purl.obolibrary.org/obo/NCIT_C5596) (Prostate Acinar Adenocarcinoma), [NCIT:C5597](http://purl.obolibrary.org/obo/NCIT_C5597) (Prostate Undifferentiated Carcinoma), [NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant), [NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant), [NCIT:C27905](http://purl.obolibrary.org/obo/NCIT_C27905) (Well Differentiated Prostate Adenocarcinoma), [NCIT:C27906](http://purl.obolibrary.org/obo/NCIT_C27906) (Moderately Differentiated Prostate Adenocarcinoma), [NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation), [NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma), [NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) 75.00%
- [UBERON:0000428](http://purl.obolibrary.org/obo/UBERON_0000428) (prostate epithelium) 75.00%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 75.00%
- [UBERON:0000077](http://purl.obolibrary.org/obo/UBERON_0000077) (mixed endoderm/mesoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 75.00%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([UBERON:0010186](http://purl.obolibrary.org/obo/UBERON_0010186) (male urethral gland))) 75.00%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([UBERON:0006868](http://purl.obolibrary.org/obo/UBERON_0006868) (seminal fluid secreting gland))) 75.00%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([UBERON:0002366](http://purl.obolibrary.org/obo/UBERON_0002366) (bulbo-urethral gland))) 75.00%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([UBERON:0002365](http://purl.obolibrary.org/obo/UBERON_0002365) (exocrine gland))) 75.00%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([UBERON:0001338](http://purl.obolibrary.org/obo/UBERON_0001338) (urethral gland))) 75.00%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([UBERON:0000414](http://purl.obolibrary.org/obo/UBERON_0000414) (mucous gland))) 75.00%
- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) and (not ([UBERON:4200230](http://purl.obolibrary.org/obo/UBERON_4200230) (surface of bone@en))) 75.00%
- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) and (not ([UBERON:4200172](http://purl.obolibrary.org/obo/UBERON_4200172) (neck of humerus))) 75.00%
- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) and (not ([UBERON:4000115](http://purl.obolibrary.org/obo/UBERON_4000115) (mineralized bone tissue))) 75.00%
- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) and (not ([UBERON:4000020](http://purl.obolibrary.org/obo/UBERON_4000020) (mineralized extracellular matrix))) 75.00%
- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) and (not ([UBERON:4000013](http://purl.obolibrary.org/obo/UBERON_4000013) (mineralized skeletal tissue))) 75.00%


